Literature DB >> 28678410

Simultaneous MR quantification of hepatic fat content, fatty acid composition, transverse relaxation time and magnetic susceptibility for the diagnosis of non-alcoholic steatohepatitis.

B Leporq1,2, S A Lambert2, M Ronot1,3, V Vilgrain1,3, B E Van Beers1,3.   

Abstract

Non-alcoholic steatohepatitis (NASH) is characterized at histology by steatosis, hepatocyte ballooning and inflammatory infiltrates, with or without fibrosis. Although diamagnetic material in fibrosis and inflammation can be detected with quantitative susceptibility imaging, fatty acid composition changes in NASH relative to simple steatosis have also been reported. Therefore, our aim was to develop a single magnetic resonance (MR) acquisition and post-processing scheme for the diagnosis of steatohepatitis by the simultaneous quantification of hepatic fat content, fatty acid composition, T2 * transverse relaxation time and magnetic susceptibility in patients with non-alcoholic fatty liver disease. MR acquisition was performed at 3.0 T using a three-dimensional, multi-echo, spoiled gradient echo sequence. Phase images were unwrapped to compute the B0 field inhomogeneity (ΔB0 ) map. The ΔB0 -demodulated real part images were used for fat-water separation, T2 * and fatty acid composition quantification. The external and internal fields were separated with the projection onto dipole field method. Susceptibility maps were obtained after dipole inversion from the internal field map with single-orientation Bayesian regularization including spatial priors. Method validation was performed in 32 patients with biopsy-proven, non-alcoholic fatty liver disease from which 12 had simple steatosis and 20 NASH. Liver fat fraction and T2 * did not change significantly between patients with simple steatosis and NASH. In contrast, the saturated fatty acid fraction increased in patients with NASH relative to patients with simple steatosis (48 ± 2% versus 44 ± 4%; p < 0.05) and the magnetic susceptibility decreased (-0.30 ± 0.27 ppm versus 0.10 ± 0.14 ppm; p < 0.001). The area under the receiver operating characteristic curve for magnetic susceptibility as NASH marker was 0.91 (95% CI: 0.79-1.0). Simultaneous MR quantification of fat content, fatty acid composition, T2 * and magnetic susceptibility is feasible in the liver. Our preliminary results suggest that quantitative susceptibility imaging has a high diagnostic performance for the diagnosis of NASH.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MRI; NASH; fatty acid composition; liver; quantitative susceptibility imaging

Mesh:

Substances:

Year:  2017        PMID: 28678410     DOI: 10.1002/nbm.3766

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  5 in total

Review 1.  How to best assess abdominal obesity.

Authors:  Hongjuan Fang; Elizabeth Berg; Xiaoguang Cheng; Wei Shen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2018-09       Impact factor: 4.294

2.  Fat spectral modeling on triglyceride composition quantification using chemical shift encoded magnetic resonance imaging.

Authors:  Gregory Simchick; Amelia Yin; Hang Yin; Qun Zhao
Journal:  Magn Reson Imaging       Date:  2018-06-19       Impact factor: 2.546

3.  Measurement of liver iron by magnetic resonance imaging in the UK Biobank population.

Authors:  Andy McKay; Henry R Wilman; Andrea Dennis; Matt Kelly; Michael L Gyngell; Stefan Neubauer; Jimmy D Bell; Rajarshi Banerjee; E Louise Thomas
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

4.  Analysis of muscle, hip, and subcutaneous fat in osteoporosis patients with varying degrees of fracture risk using 3T Chemical Shift Encoded MRI.

Authors:  Dimitri Martel; Stephen Honig; Anmol Monga; Gregory Chang
Journal:  Bone Rep       Date:  2020-03-24

5.  Favorable fatty acid composition in adipose tissue in healthy Iraqi- compared to Swedish-born men - a pilot study using MRI assessment.

Authors:  Lena Trinh; Karin G Stenkula; Lars E Olsson; Jonas Svensson; Pernilla Peterson; Louise Bennet; Sven Månsson
Journal:  Adipocyte       Date:  2022-12       Impact factor: 4.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.